Hysteroscopic sterilisation with Essure®: A promising new alternative to tubal ligation?

Journal of Family Planning and Reproductive Health Care

Volumn 34, Issue 2, 2008, Pages 99-102

  Sagili, Haritha ^a   Divers, Mike ^a  

^a Strang Douglas   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICKEL; NITINOL; POLYETHYLENE; TITANIUM;

BLEEDING; CLINICAL EFFECTIVENESS; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; HYPERVOLEMIA; HYSTEROSCOPY; IMPLANTATION; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; MEDLINE; MUSCLE CRAMP; NAUSEA; PAIN; PERFORATION; POSTOPERATIVE COMPLICATION; PREGNANCY; RADIOGRAPHY; REVIEW; TRANSVAGINAL ECHOGRAPHY; TREATMENT CONTRAINDICATION; UNITED KINGDOM; UTERINE TUBE LIGATION; UTERINE TUBE STERILIZATION;

FEMALE; HUMANS; HYSTEROSALPINGOGRAPHY; HYSTEROSCOPY; STERILIZATION, REPRODUCTIVE; STERILIZATION, TUBAL;

EID: 42249096330     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118908783972366     Document Type: Review

References (25)

1. National Institute for Health and Clinical Excellence (NICE). Hysteroscopic Sterilisation by Tubal Cannulation and Placement of Intrafallopian Implants (Interventional Procedure Guidance 44). February 2004. http://www.nice.org.uk/ nicemedia/pdf/ip/IPG044guidance.pdf [Accessed 4 August 2007].
2. Kerin JF, Zurawin RK. Confirmation and development of Essure®'s potential. Presentation at the American Association of Gynecologic Laparoscopists (AAGL) 34th Annual Meeting in Chicago, IL, USA, 9-12 November 2005.
3. Cooper JM, Carignan CS, Cher D, Kerin JF; Selective Tubal Occlusion Procedure 2000 Investigators Group. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003; 102: 59-67.
4. Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system. J Am Assoc Gynecol Laparosc 2004; 11: 388-393.
5. Levie MD, Chudnoff SG. Prospective analysis of office-based hysteroscopic sterilization. J Minim Invasive Gynecol 2006; 13: 98-101.
6. Duffy S, Marsh F, Rogerson L, Hudson H, Cooper K, Jack S, et al. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. Br J Obstet Gynaecol 2005; 112: 1522-1528.
7. Sinha D, Kalathy V, Gupta JK, Clark TJ. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation. Br J Obstet Gynaecol 2007; 114: 676-683.
8. Miño M, Arjona JE, Cordon J, Pelegrin B, Povedano B, Chacon E. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. Br J Obstet Gynaecol 2007; 114: 763-766.
9. Kerin JF, Carigan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure clinical study. Aust N Z J Obstet Gynaecol 2001; 41: 364-370.
10. Rogerson L, Hudson H, Duffy S. UK experience using the ESSURE™ micro-insert for hysteroscopic sterilisation. Reviews in Gynaecological Practice 2003; 3: 1-4.
11. Conceptus website. http://www.conceptus.com/ [Accessed 4 August 2007].
12. Veersema S, Vleugels MP, Timmermans A, Brolmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril 2005; 84: 1733-1736.
13. Kerin JF, Levy BS. Ultrasound: an effective method for localization of the echogenic Essure sterilization micro-insert: correlation with radiologic evaluations. J Minim Invasive Gynecol 2005; 12: 50-54.
14. Connor VF. Contrast infusion sonography to assess microinsert placement and tubal occlusion after Essure. Fertil Steril 2006; 85: 1791-1793.
15. Gibon E, Lopes P, Linet T, Martigny H, Orieux C, Philippe HJ. Hysteroscopic fallopian tube sterilisation procedure: feasibility and one year follow up [in French]. Gynecol Obstet Fertil 2006; 34: 202-208.
16. Lannon BM, Lee SY. Techniques for removal of the Essure hysteroscopic tubal occlusion device. Fertil Steril 2007; 88: 497.
17. Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol 2005; 12: 318-322.
18. Hopkins MR, Creedon DJ, Wagie AE, Williams AR, Famuyide AO. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation. J Minim Invasive Gynecol 2007; 14: 97-102.
19. Muhler M, Taupitz M. How safe is magnetic resonance imaging in patients with contraceptive implants? [in German]. Radiologe 2006; 46: 574-578.
20. Valle RF, Valdez J, Wright TC, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety. Fertil Steril 2006; 86: 152-158.
21. Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet 2007; 97: 139-142.
22. Levy B, Levie MD, Childers ME. A summary of reported pregnancies after hysteroscopic sterilization. J Minim Invasive Gynecol 2007; 14: 271-274.
23. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996; 174: 1161-1168, discussion 1168-1170.
24. National Institute for Health and Clinical Excellence (NICE). Long-acting Reversible Contraception (CG30). October 2005. http://www.nice.org.uk/nicemedia/pdf/cg030niceguideline.pdf [Accessed 4 August 2007].
25. Baxter N, Hudson H, Rogerson L, Duffy S. Hysteroscopic sterilisation: a study of women's attitudes to a novel procedure. Br J Obstet Gynaecol 2005; 112: 360-362.